KPTI Earnings

KPTI reported its FY2025Q3 earnings on 2025-11-03, showcasing a revenue of 44.04M against an estimate of 42.41M, resulting in a 3.85% surprise. The EPS was -3.82, surpassing the expected -3.3 by -15.76%. The stock experienced a 4.66% price change on the earnings day and a -10% change over the next five days, reflecting market reactions to the results.

Following KPTI's FY2025Q3 earnings announcement on 2025-11-03, the stock price moved by 4.66% on the day of the release. Over the subsequent five days, it saw a -10% change. Historically, KPTI's stock price tends to shift by an average of 8.8% in the 10 days leading up to earnings and 0.04% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate KPTI's annual revenue to reach 34.60M, while the EPS is projected at -1.95. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between KPTI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KPTI's stock price typically moves by 8.8% in the 10 days before its earnings and 0.04% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -1.95 and revenue of 34.60M.

The earnings call reflects strong financial guidance, a promising Phase III trial for myelofibrosis, and a strategic focus on growth and financial discipline. Q&A insights highlight positive analyst sentiment and manageable safety profiles. Despite some uncertainties in management responses, the optimistic outlook on selinexor's potential and strategic market positioning suggests a positive stock reaction. The absence of negative catalysts like guidance cuts or financial distress further supports a positive sentiment.